Latest News and Press Releases
Want to stay updated on the latest news?
-
Industry analysis compares FDA-approved Wegovy pricing from $149 oral to Ro's $199 injectable as telehealth access expands for 2026.
-
Analysis examines best tirzepatide access pathways for 2026 including FDA regulatory changes, insurance coverage shifts, and cash-pay options.
-
FDA approves first oral GLP-1 for weight loss as patients evaluate Wegovy, Zepbound, and compounded options. MEDVi lists programs from $179.
-
Independent analysis reviews best TRT injection for 2026 as Fridays lists prescription testosterone in injectable and oral telehealth formats.
-
Sprout Health lists prescription NAD+ injections at $149 first month through telehealth platform as consumer interest in compounded NAD+ grows.
-
Analysis examines Direct Meds GLP-1 medications platform as LegitScript-certified telehealth option for compounded semaglutide and tirzepatide access.
-
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable and needle-free formats.
-
FDA approves oral Wegovy pill Dec 2025. Analysis compares FDA-approved injectable, oral, and compounded semaglutide access pathways for 2026.
-
bmiMD lists mint sublingual sermorelin tablets at $79/month via telehealth as peptide wellness searches surge 340% pre-2026. Compounded Rx analysis.
-
Connell Consulting Business Agency, LLC is lobbying against baseless tort repealFlorida Representative Weinberger of House District 94 and State Senator Grall of Senate District 29 refile tried and...